BIIB
USDBiogen Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$155.700
Kõrge
$156.220
Madal
$154.010
Maht
1.72M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
22.7B
Tööstusharu
Drug Manufacturers - General
Riik
United States
Kauplemisstatistika
Keskmine maht
1.64M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Bernstein Maintains Market Perform on Biogen, Raises Price Target to $157
Bernstein analyst William Pickering maintains Biogen with a Market Perform and raises the price target from $155 to $157.
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of action of felzartamab and advancing the understanding of its disease
RBC Capital Maintains Outperform on Biogen, Lowers Price Target to $210
RBC Capital analyst Brian Abrahams maintains Biogen with a Outperform and lowers the price target from $217 to $210.
Biogen tops quarterly profit estimates, eyes deals to build early-stage pipeline
Biogen beat Wall Street estimates for third-quarter profit, helped by better-than-expected sales of some of its multiple sclerosis treatments.
Seotud aktsiad
MSC
Studio City International Holdings Limited American depositary shares each representing four ordinary shares
HUM
Humana
TMO
Thermo Fisher Scientific
AAL
American Airlines Group Inc.
CSGP
CoStar Group Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.